CEP
NASDAQ
US
Cantor Equity Partners, Inc. - Class A ordinary shares
$14.43
-0.07 (-0.5%)
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$6.2B
P/E
1427.3
ROE
4.2%
D/E
0.86
Beta
3.35
52W
$9–$60
Price Chart
Similar Stocks
Earnings
Next Report
May 13, 2026
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | — | — | — |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 2.7% | — | 2.7% | 2.7% | 2.7% | 4.2% |
| P/E (TTM) | 128.44 | 140.83 | 108.06 | 84.63 | 41.69 | 1427.30 |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.63 | 0.48 | 0.63 | 0.63 | 0.63 | 0.86 |
| Current Ratio | 0.20 | 0.35 | 0.20 | 0.20 | 0.20 | 0.13 |
Key Ratios
ROA (TTM)
4.2%
P/B
1.3
EPS (TTM)
$0.34
52W High
$59.75
52W Low
$9.05
$9.05
52-Week Range
$59.75
How does CEP compare to N/A peers?
Peer group: Mid-cap N/A ($2B+) · 2 companies
CEP
CSQ
CEP valuation vs N/A peers
P/E ratio
1427.3
▼
0%
below
peers
(1427.3)
vs Peers
vs Industry
Undervalued
P/S ratio
—
—
vs Peers
vs Industry
Undervalued
P/B ratio
1.3
▲
0%
above
peers
(1.3)
vs Peers
vs Industry
Undervalued
Div yield
—
—
vs Peers
vs Industry
Low yield
CEP profitability vs N/A peers
ROE
4.2%
▲
0%
above
peers
(4.2%)
vs Peers
vs Industry
Weak
Net margin
—
—
vs Peers
vs Industry
Weak
Gross margin
—
—
vs Peers
vs Industry
Weak
ROA
4.2%
▲
0%
above
peers
(4.2%)
vs Peers
vs Industry
Weak
CEP financial health vs N/A peers
D/E ratio
0.9
▼
96%
below
peers
(24.5)
vs Peers
vs Industry
Low debt
Current ratio
0.1
▼
98%
below
peers
(5.9)
vs Peers
vs Industry
Low liquidity
Beta
3.4
▲
44%
above
peers
(2.3)
vs Peers
vs Industry
More volatile
CEP fundamentals radar
CEP
Peer median
Industry
CEP profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
CEP vs peers: key metrics
Latest News
Debris from aerial interception strikes Oracle building in Dubai, UAE says
CNBC · Apr 04
Allegations Of Pentagon "Casualty Cover-Up": The Intercept
ZeroHedge · Apr 03
Employers are using your personal data to figure out the lowest salary …
Yahoo Finance · Apr 03
NexMetals Mining (NEXM) Extends Selebi Flexure Zone With New Massive Sulphide Intercept
Yahoo Finance · Apr 02
Merck's WINREVAIR Phase 2 CADENCE Trial Shows Positive Proof-of-Concept In Pulmonary Hypertension
Nasdaq · Mar 29